Ginkgo Bioworks (NYSE:DNA) Stock Gains Momentum After Partnership to Develop Animal-Free Egg Products

May 13, 2022

Ginkgo Bioworks (NYSE:DNA), which is best known for operating a horizontal platform meant for cell programming, was one of the companies to have come into focus among investors yesterday and saw its stock end the day with gains of as much as 8%. Trading Data On Thursday, DNA stock moved up 8.18% to $2.38 with more than 26.62 million shares, compared to its average volume of 19.25 million shares. The…

Read More >>